Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SERENE ER Analysis Part 2 SERENE-UC: Exposure-response Analysis of Higher Versus Standard Adalimumab Dosing Regimens for Patients with Moderately to Severely Active Ulcerative Colitis.
Stodtmann S, Chen MJ, Ponce-Bobadilla AV, Finney-Hayward TK, Kalabic J, Mostafa NM. Stodtmann S, et al. Among authors: ponce bobadilla av. Clin Pharmacol Drug Dev. 2024 Sep;13(9):1033-1043. doi: 10.1002/cpdd.1437. Epub 2024 Jul 2. Clin Pharmacol Drug Dev. 2024. PMID: 38953600 Clinical Trial.
SERENE ER Analysis Part 1-SERENE CD: Exposure-Response Analysis of Higher Versus Standard Adalimumab Dosing Regimens for Patients With Moderately to Severely Active Crohn Disease.
Chen MJ, Ponce-Bobadilla AV, Stodtmann S, Song AP, Finney-Hayward TK, Mostafa NM. Chen MJ, et al. Among authors: ponce bobadilla av. Clin Pharmacol Drug Dev. 2024 Sep;13(9):1024-1032. doi: 10.1002/cpdd.1438. Epub 2024 Jul 2. Clin Pharmacol Drug Dev. 2024. PMID: 38953542 Clinical Trial.
Integrating machine learning with pharmacokinetic models: Benefits of scientific machine learning in adding neural networks components to existing PK models.
Valderrama D, Ponce-Bobadilla AV, Mensing S, Fröhlich H, Stodtmann S. Valderrama D, et al. Among authors: ponce bobadilla av. CPT Pharmacometrics Syst Pharmacol. 2024 Jan;13(1):41-53. doi: 10.1002/psp4.13054. Epub 2023 Oct 16. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 37843389 Free PMC article.
Assessing the Impact of Immunogenicity and Improving Prediction of Trough Concentrations: Population Pharmacokinetic Modeling of Adalimumab in Patients with Crohn's Disease and Ulcerative Colitis.
Ponce-Bobadilla AV, Stodtmann S, Chen MJ, Winzenborg I, Mensing S, Blaes J, Haslberger T, Laplanche L, Dreher I, Mostafa NM. Ponce-Bobadilla AV, et al. Clin Pharmacokinet. 2023 Apr;62(4):623-634. doi: 10.1007/s40262-023-01221-x. Epub 2023 Mar 11. Clin Pharmacokinet. 2023. PMID: 36905528